Balentine LLC Ionis Pharmaceuticals Inc Transaction History

Balentine LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$47.45 - $62.95 $40,095 - $53,192	-845 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $11,197 - $14,590	239 Added 39.44%	845 $50,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $25,985 - $32,542	606 New	606 $31,000
Q1 2018 May 16, 2018	SELL	$44.08 - $55.05 $68,059 - $84,997	-1,544 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$45.56 - $59.57 $70,344 - $91,976	1,544	1,544 $78,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.69B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.